NATURE AND OBJECTIVES OF THE PROJECT Patients who suffer from addiction to opioids often experience depression. Furthermore, data concerning the use of effective medication to treat depression in patients addicted to opioids is insufficient. Desvenlafaxine is an antidepressant that has been approved in Canada to treat depression within the general population. We hereby intend to […]
Read More